$36.81

-0.90 (-2.39%)

After Hours: $38.11 (+1.30, +3.52%)

Weekly Expected Move ±3.8%

$35 $36 $38 $39 $40

NYSE · Real Estate · REIT - Healthcare Facilities · Tech Score Sell · Power 39 · $524.1M mcap · 13M float · 1.27% daily turnover · Short 40% of daily vol

Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾

Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$99M +0.2% ▲

5Y CAGR: +4.9%

Gross Profit

$7M -92.1% ▼

5Y CAGR: -36.9%

Operating Income

$39M +6.8% ▲

5Y CAGR: +8.6%

Net Income

$18M -8.4% ▼

5Y CAGR: -2.0%

EPS (Diluted)

$1.27 -8.6% ▼

5Y CAGR: -2.1%

EBITDA

$81M +15.2% ▲

5Y CAGR: +8.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$84M	$91M	$96M	$99M	$99M
YoY Growth	+7.9%	+7.6%	+5.5%	+3.6%	+0.2%
Cost of Revenue	$4M	$5M	$5M	$5M	$92M
Gross Profit	$80M	$86M	$90M	$94M	$7M
Gross Margin	94.8%	94.4%	94.4%	94.5%	7.5%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$0	$0	$0	$0	$0
Operating Expenses	$51M	$55M	$59M	$57M	-$32M
Operating Income	$29M	$31M	$31M	$37M	$39M
Operating Margin	34.3%	33.8%	32.8%	37.2%	39.6%
Interest Expense	$9M	$11M	$22M	$24M	$22M
Income Before Tax	$109M	$21M	$15M	$19M	$18M
Tax Expense	$0	$0	$0	$0	$0
Net Income	$109M	$21M	$15M	$19M	$18M
Net Margin	129.7%	23.3%	16.1%	19.4%	17.8%
EPS (Diluted)	$7.92	$1.53	$1.11	$1.39	$1.27
EBITDA	$145M	$58M	$65M	$70M	$81M
Shares Outstanding	14M	14M	14M	14M	14M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$24M	$25M	$25M	$25M	$25M	$74M	$25M	$25M
Cost of Revenue	$1M	$1M	$1M	$1M	$1M	$4M	$7M	$23M
Gross Profit	$23M	$23M	$23M	$23M	$24M	$70M	$17M	$2M
Gross Margin	94.3%	94.4%	94.4%	94.4%	94.4%	94.4%	70.6%	8.7%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$0	$0	$0	$0	$0	$0	$1M	$1M
Operating Expenses	$15M	$14M	$14M	$15M	$15M	$42M	$8M	-$7M
Operating Income	$8M	$9M	$9M	$9M	$8M	$28M	$9M	$9M
Operating Margin	34.7%	37.6%	36.8%	35.6%	33.2%	37.4%	36.5%	36.8%
Interest Expense	$6M	$6M	$5M	$5M	$16M	$3M	$5M	$4M
Income Before Tax	$4M	$5M	$5M	$4M	$4M	$4M	$5M	$6M
Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$4M	$5M	$5M	$4M	$4M	$4M	$5M	$6M
Net Margin	16.3%	18.9%	19.5%	18.1%	15.9%	5.8%	20.5%	23.6%
EPS (Diluted)	$0.29	$0.34	$0.34	$0.32	$0.29	$0.32	$0.36	$0.43
EBITDA	$17M	$17M	$17M	$17M	$17M	$14M	$16M	$17M
Shares Outstanding	14M	14M	14M	14M	14M	14M	14M	14M

UHT NYSE